Beijing Hotgen Biotech Co., Ltd. (688068.SS)
CNY 52.76
(-1.59%)
CNY 52.76
(-1.59%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 15.25 Million CNY | -63.79% |
| 2022 | 42.13 Million CNY | 17.11% |
| 2021 | 35.97 Million CNY | 35.74% |
| 2020 | 26.5 Million CNY | 11.6% |
| 2019 | 23.75 Million CNY | 0.0% |
| 2018 | - CNY | -100.0% |
| 2017 | 155.57 Thousand CNY | -95.11% |
| 2016 | 3.18 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 5.34 Million CNY | -39.91% |
| 2024 Q1 | 8.89 Million CNY | -41.71% |
| 2024 Q3 | 337.4 Thousand CNY | 52.43% |
| 2023 Q1 | 25.66 Million CNY | -39.08% |
| 2023 Q2 | 22.68 Million CNY | -11.61% |
| 2023 Q4 | 15.25 Million CNY | -20.85% |
| 2023 Q3 | 19.27 Million CNY | -15.05% |
| 2023 FY | 15.25 Million CNY | -63.79% |
| 2022 Q4 | 42.13 Million CNY | 53.95% |
| 2022 Q3 | 27.36 Million CNY | -9.77% |
| 2022 Q1 | 35.5 Million CNY | -1.3% |
| 2022 Q2 | 30.33 Million CNY | -14.58% |
| 2022 FY | 42.13 Million CNY | 17.11% |
| 2021 Q2 | 23.87 Million CNY | -5.48% |
| 2021 Q1 | 25.26 Million CNY | 1.62% |
| 2021 FY | 35.97 Million CNY | 35.74% |
| 2021 Q3 | 20.45 Million CNY | -14.35% |
| 2021 Q4 | 35.97 Million CNY | 75.91% |
| 2020 FY | 26.5 Million CNY | 11.6% |
| 2020 Q2 | - CNY | -100.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | 24.85 Million CNY | 0.0% |
| 2020 Q1 | 23.75 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 23.75 Million CNY | 0.0% |
| 2019 Q4 | 23.75 Million CNY | -5.0% |
| 2019 Q3 | 25 Million CNY | 0.0% |
| 2019 Q2 | 25 Million CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | -100.0% |
| 2017 FY | 155.57 Thousand CNY | -95.11% |
| 2016 FY | 3.18 Million CNY | 0.0% |